380 related articles for article (PubMed ID: 16877391)
1. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern.
Lindegaard J; Isager P; Prause JU; Heegaard S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391
[TBL] [Abstract][Full Text] [Related]
2. Optic nerve invasion of uveal melanoma.
Lindegaard J; Isager P; Prause JU; Heegaard S
APMIS; 2007 Jan; 115(1):1-16. PubMed ID: 17223846
[TBL] [Abstract][Full Text] [Related]
3. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
5. Expression of neurotrophin receptors by retinoinvasive uveal melanoma.
Milman T; Hu DN; McCormick SA; Eagle RC; Crawford JB; Chin K; Shields CL; Shields JA; Char DH; Finger PT
Melanoma Res; 2012 Apr; 22(2):164-8. PubMed ID: 22343487
[TBL] [Abstract][Full Text] [Related]
6. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.
Wilson MW; Rodriguez-Galindo C; Billups C; Haik BG; Laningham F; Patay Z
Ophthalmology; 2009 Aug; 116(8):1558-63. PubMed ID: 19545904
[TBL] [Abstract][Full Text] [Related]
9. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
10. Extraocular extension of unrecognized choroidal melanoma simulating a primary optic nerve tumor: report of two cases.
Shields CL; Santos MC; Shields JA; Singh AD; Eagle RC
Ophthalmology; 1999 Jul; 106(7):1349-52. PubMed ID: 10406620
[TBL] [Abstract][Full Text] [Related]
11. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
Braun UC; Rummelt VC; Naumann GO
Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
[TBL] [Abstract][Full Text] [Related]
12. Eye-wall resection.
Char DH; Miller T; Crawford JB
Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
Kroll S; Char DH; Quivey J; Castro J
Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
[TBL] [Abstract][Full Text] [Related]
14. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
15. Uveal melanoma: management and outcome of patients with extraocular spread.
Bellmann C; Lumbroso-Le Rouic L; Levy C; Plancher C; Dendale R; Sastre-Garau X; Asselain B; Desjardins L
Br J Ophthalmol; 2010 May; 94(5):569-74. PubMed ID: 19965816
[TBL] [Abstract][Full Text] [Related]
16. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.
Canovas D; Rennie IG; Nichols CE; Sisley K
Cancer; 2008 Apr; 112(8):1787-94. PubMed ID: 18300240
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factor study of survival after enucleation for juxtapapillary melanomas.
Weinhaus RS; Seddon JM; Albert DM; Gragoudas ES; Robinson N
Arch Ophthalmol; 1985 Nov; 103(11):1673-7. PubMed ID: 4062633
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
Khelfaoui F; Validire P; Auperin A; Quintana E; Michon J; Pacquement H; Desjardins L; Asselain B; Schlienger P; Vielh P
Cancer; 1996 Mar; 77(6):1206-13. PubMed ID: 8635145
[TBL] [Abstract][Full Text] [Related]
20. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
